WASHINGTON (AP) — A case before the Supreme Court today could have major implications for medical research and the biotech industry.
The court is being asked to decide whether DNA patents are legal.
The industry says they need to recoup the costs of research, which would be slowed if patents are disallowed.
Opponents say the opposite is true; that the lack of patents will broaden medical research.